2315 related items for PubMed ID: 2832438
1. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG, Liu J, Ulmann A, Baulieu E, Yen SS.
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[Abstract] [Full Text] [Related]
2. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
Liu JH, Garzo G, Morris S, Stuenkel C, Ulmann A, Yen SS.
J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
[Abstract] [Full Text] [Related]
3. Luteal contraception.
Yen S, Garzo G, Liu J.
Contraception; 1987 Dec; 36 Suppl():13-25. PubMed ID: 2824125
[Abstract] [Full Text] [Related]
4. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
Schaison G, George M, Lestrat N, Reinberg A, Baulieu EE.
J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
[Abstract] [Full Text] [Related]
5. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB, Salvatierra AM, Romero C, Spitz IM.
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[Abstract] [Full Text] [Related]
6. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
Roseff SJ, Kettel LM, Rivier J, Burger HG, Baulieu E, Yen SS.
Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
[Abstract] [Full Text] [Related]
7. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R, Messinis LE, Fowler P, Groome NP, Knight PG, Templeton AA.
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[Abstract] [Full Text] [Related]
8. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
Greene KE, Kettel LM, Yen SS.
Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
[Abstract] [Full Text] [Related]
9. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
Heikinheimo O, Gordon K, Williams RF, Hodgen GD.
Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
[Abstract] [Full Text] [Related]
10. The effects of progesterone receptor blockade in the luteal phase of normal fertile women.
Li TC, Dockery P, Thomas P, Rogers AW, Lenton EA, Cooke ID.
Fertil Steril; 1988 Nov; 50(5):732-42. PubMed ID: 3181485
[Abstract] [Full Text] [Related]
11. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
Swahn ML, Johannisson E, Daniore V, de la Torre B, Bygdeman M.
Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
[Abstract] [Full Text] [Related]
12. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
Croxatto HB, Salvatierra AM, Croxatto HD, Spitz IM.
Clin Endocrinol (Oxf); 1989 Jul; 31(1):15-23. PubMed ID: 2598478
[Abstract] [Full Text] [Related]
13. Response to intermittent RU486 in women.
Spitz IM, Croxatto HB, Salvatierra AM, Heikinheimo O.
Fertil Steril; 1993 May; 59(5):971-5. PubMed ID: 8486197
[Abstract] [Full Text] [Related]
14. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R, Alfthan H, Haukkamaa M, Heikinheimo O, Luukkainen T, Lähteenmäki P.
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[Abstract] [Full Text] [Related]
15. Acute effects of progesterone and the antiprogestin RU 486 on gonadotropin secretion in the follicular phase of the menstrual cycle.
Permezel JM, Lenton EA, Roberts I, Cooke ID.
J Clin Endocrinol Metab; 1989 May; 68(5):960-5. PubMed ID: 2497130
[Abstract] [Full Text] [Related]
16. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
Jewelewicz R, Dyrenfurth I, Ferin M, Bogumil J, Vande Wiele RL.
J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
[Abstract] [Full Text] [Related]
17. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
Grimes EM, Thompson IE, Taymor ML.
Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
[Abstract] [Full Text] [Related]
18. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
Lemay A, Faure N.
J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
[Abstract] [Full Text] [Related]
19. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E, Fauser BC.
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[Abstract] [Full Text] [Related]
20. Effects of aging on the hypothalamic-hypophyseal-gonadal axis in female rats.
McPherson JC, Costoff A, Mahesh VB.
Fertil Steril; 1977 Dec; 28(12):1365-70. PubMed ID: 201506
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
